Twist Bioscience Corporation (TWST)
USD 38.42
(4.89%)
USD 38.42
(4.89%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -192.4 Million USD | 32.2% |
| 2022 | -283.77 Million USD | 29.57% |
| 2021 | -402.9 Million USD | -598.46% |
| 2020 | -57.68 Million USD | -47.9% |
| 2019 | -39 Million USD | 45.1% |
| 2018 | -71.03 Million USD | -221.84% |
| 2017 | -22.07 Million USD | -26.75% |
| 2016 | -17.41 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -151.96 Million USD | 1.27% |
| 2024 Q2 | -153.92 Million USD | 11.74% |
| 2024 Q1 | -174.39 Million USD | 9.36% |
| 2023 Q3 | -214.42 Million USD | 4.26% |
| 2023 Q4 | -192.4 Million USD | 10.27% |
| 2023 FY | -192.4 Million USD | 32.2% |
| 2023 Q1 | -222.7 Million USD | 21.52% |
| 2023 Q2 | -223.97 Million USD | -0.57% |
| 2022 Q4 | -283.77 Million USD | 4.66% |
| 2022 FY | -283.77 Million USD | 29.57% |
| 2022 Q3 | -297.65 Million USD | 9.24% |
| 2022 Q2 | -327.96 Million USD | -176.4% |
| 2022 Q1 | -118.65 Million USD | 70.55% |
| 2021 Q3 | -411.52 Million USD | -12.01% |
| 2021 Q4 | -402.9 Million USD | 2.09% |
| 2021 Q2 | -367.4 Million USD | -16.74% |
| 2021 Q1 | -314.7 Million USD | -445.56% |
| 2021 FY | -402.9 Million USD | -598.46% |
| 2020 Q2 | -143.92 Million USD | -952.61% |
| 2020 Q1 | 16.88 Million USD | 143.28% |
| 2020 FY | -57.68 Million USD | -47.9% |
| 2020 Q4 | -57.68 Million USD | 66.05% |
| 2020 Q3 | -169.93 Million USD | -18.08% |
| 2019 Q4 | -39 Million USD | 34.74% |
| 2019 Q3 | -59.76 Million USD | -205.96% |
| 2019 Q2 | -19.53 Million USD | 65.49% |
| 2019 FY | -39 Million USD | 45.1% |
| 2019 Q1 | -56.6 Million USD | 20.33% |
| 2018 Q4 | -71.03 Million USD | 12.69% |
| 2018 Q1 | 62.2 Million USD | 381.81% |
| 2018 FY | -71.03 Million USD | -221.84% |
| 2018 Q3 | -81.36 Million USD | 0.0% |
| 2017 Q4 | -22.07 Million USD | 0.0% |
| 2017 FY | -22.07 Million USD | -26.75% |
| 2016 FY | -17.41 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | -387.684% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | -3153.292% |
| Aspira Women's Health Inc. | -331 Thousand USD | -58027.19% |
| Biodesix, Inc. | 34.3 Million USD | 660.821% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | -3219.582% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -15379.62% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -15379.62% |
| Bionano Genomics, Inc. | 34.88 Million USD | 651.577% |
| CareDx, Inc | -47.97 Million USD | -301.036% |
| Check-Cap Ltd. | -24.75 Million USD | -677.189% |
| Castle Biosciences, Inc. | -83.53 Million USD | -130.335% |
| DarioHealth Corp. | -7.54 Million USD | -2449.033% |
| Exact Sciences Corporation | 1.94 Billion USD | 109.87% |
| Fulgent Genetics, Inc. | -82.56 Million USD | -133.027% |
| Guardant Health, Inc. | 220.22 Million USD | 187.365% |
| ICON Public Limited Company | 3.56 Billion USD | 105.404% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 138.952% |
| Illumina, Inc. | 1.21 Billion USD | 115.849% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | -3441.563% |
| iSpecimen Inc. | -2.14 Million USD | -8859.627% |
| Standard BioTools Inc. | 46.5 Million USD | 513.712% |
| MDxHealth SA | 18.88 Million USD | 1118.803% |
| 23andMe Holding Co. | -141.37 Million USD | -36.096% |
| Medpace Holdings, Inc. | -103.32 Million USD | -86.206% |
| Myriad Genetics, Inc. | 88.1 Million USD | 318.389% |
| Mainz Biomed B.V. | 349.85 Thousand USD | 55094.498% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | -7786.89% |
| NeoGenomics, Inc. | 269.19 Million USD | 171.474% |
| Neogen Corporation | 735.62 Million USD | 126.155% |
| Inotiv, Inc. | 382.14 Million USD | 150.347% |
| Natera, Inc. | -200.1 Million USD | 3.849% |
| OpGen, Inc. | 11.89 Million USD | 1717.919% |
| OPKO Health, Inc. | 230.68 Million USD | 183.405% |
| Psychemedics Corporation | 334 Thousand USD | 57705.09% |
| Prenetics Global Limited | -43.33 Million USD | -343.964% |
| Prenetics Global Limited | -43.33 Million USD | -343.964% |
| Precipio, Inc. | -386 Thousand USD | -49744.819% |
| Personalis, Inc. | -8.02 Million USD | -2298.417% |
| RadNet, Inc. | 1.14 Billion USD | 116.752% |
| Sera Prognostics, Inc. | -2.02 Million USD | -9415.381% |
| Sotera Health Company | 2.02 Billion USD | 109.499% |
| Neuronetics, Inc. | 2.79 Million USD | 6978.834% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -1154.489% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -1154.489% |
| Trinity Biotech plc | 63.73 Million USD | 401.872% |
| T2 Biosystems, Inc. | 33.8 Million USD | 669.082% |
| Exagen Inc. | -12.77 Million USD | -1406.428% |